All articles tagged with #lipodystrophy
Researchers found that hormone-sensitive lipase, long viewed solely as a fat-mobilizing enzyme, also enters the nucleus of fat cells to regulate adipose tissue health. This nuclear role helps explain why HSL deficiency leads to lipodystrophy and how fat-tissue dysfunction links obesity with metabolic disease, potentially opening new paths to treat obesity by targeting fat-cell health rather than weight alone.
Scientists found that hormone-sensitive lipase (HSL), long known for releasing fat, also operates inside the nucleus of fat cells to maintain healthy adipose tissue and regulate metabolic processes. Loss of this nuclear HSL leads to lipodystrophy rather than obesity, helping explain why fat quality matters and suggesting obesity therapies should aim to preserve fat‑cell function, not just reduce fat mass.
New research links fat tissue dysfunction to metabolic disease, showing that both excess fat and losing fat improperly disrupt lipid storage, trigger inflammation and mitochondrial dysfunction, and raise risks of diabetes and fatty liver, highlighting therapies that protect or restore adipose tissue.
Scientists have discovered a new role for hormone-sensitive lipase (HSL) in the nucleus of fat cells, where it helps maintain healthy adipose tissue, explaining the paradox of fat loss in HSL deficiency and opening new avenues for understanding metabolic diseases like obesity and lipodystrophy.